alti20131205_8k.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (date of earliest event reported): December 4, 2013

 

Altair Nanotechnologies Inc.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

 

1-12497

 

33-1084375

(State or other jurisdiction of

 

(Commission

 

(IRS Employer

incorporation or organization) 

 

File Number)

 

Identification No.)

 

 

204 Edison Way

 

 

Reno, NV

 

89502

(Address of Principal Executive Offices) 

 

(Zip Code)

 

 

 

Registrant's Telephone Number, Including Area Code:

 

 

(775) 856-2500

 

 

 

N/A

(Former name, former address, and formal fiscal year, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 

 

[ ]

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

[ ]

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

[ ]

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

[ ]

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)

 

 

 
 
 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On December 6, 2013, Bruce Sabacky resigned his position as Chief Technology Officer of the Company. He is expected to remain an employee in the near future.

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders

 

On December 4, 2013, the Company held an annual meeting of stockholders (the “Meeting”). The stockholders approved all proposals considered at the Meeting and approved all nominees of the Company for director, as follows:

 

1.              The following persons were elected to serve as directors, each to serve until the next annual meeting of stockholders of the Company or until their respective successor shall have been duly elected, unless they are earlier resign or are removed:

 

Name of Nominee

  

Votes For

    

Votes

Withheld

    

Broker

Non-Votes

  

Yincang Wei

     6,499,153       140,423       2,319,284  

Guohua Sun

     6,498,976       140,600       2,319,284  

Yuhong Li

     6,605,900       33,676       2,319,284  

Richard W. Lee

     6,577,939       61,637       2,319,284  

Zhigang Zhao

     6,579,778       59,798       2,319,284  

Dr. Chin Chuen Chan

     6,581,090       58,486       2,319,284  

Guohua Wei

     6,578,783       60,793       2,319,284  

Eqbal Al Yousuf

     6,605,357       34,219       2,319,284  

Jun Liu

     6,499,266       140,310       2,319,284  

 

 

2.              The proposal to appoint Crowe Horwath LLP as the independent public accounting firm of the Company for the fiscal year ending December 31, 2013 and to authorize the Audit Committee of the Board to fix their remuneration was approved based upon the following vote:

 

Votes For

     8,880,404    

Votes Against

     44,743    

Abstain

     33,713    

Broker Non-Votes

     0    

 

 
2 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Altair Nanotechnologies Inc.

 

 

 

 

 

 

 

 

 

Dated: December 6, 2013

By

/s/ Paula Conroy     

 

 

Paula Conroy, Chief Financial Officer

 

 

 

 

3